百花医药 (600721.sh)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(百花医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 90,876,390.38369,277,391.90265,713,871.38167,213,932.1275,710,434.22349,884,562.47256,357,915.51163,762,744.5458,796,482.88
 营业利润(元) 21,980,744.7917,955,943.6520,772,955.8515,054,298.587,425,391.87-30,740,382.2513,960,694.4312,223,845.352,011,349.59
 利润总额(元) 22,019,721.9116,481,542.0820,346,669.1914,680,149.017,395,460.49-32,115,490.8113,009,169.0811,655,832.802,005,268.37
 净利润(元) 20,663,459.0212,972,337.9517,691,786.7212,999,556.436,686,853.20-34,727,505.4910,995,714.3710,313,569.561,378,890.58
 归属于母公司股东的净利润(元) 20,663,459.0212,972,337.9517,691,786.7212,999,556.436,686,853.20-34,754,970.4810,995,714.3710,294,461.261,372,156.64
盈利能力:
 销售毛利率(%) 52.2649.0448.2146.7748.9539.9241.5341.5646.12
 销售净利率(%) 22.743.516.667.778.83-9.934.296.302.35
 净资产收益率(%) 2.941.892.501.890.98----
 总资产报酬率ROA(%) 2.071.511.921.420.74----
 投入资本回报率ROIC(%) 2.881.892.571.920.99-5.131.581.490.20
营运能力:
 存货周转率(次) 0.301.370.830.510.22----
 应收账款周转率(次) 3.9720.6311.247.263.69----
 总资产周转率(次) 0.090.360.260.170.08----
偿债能力:
 资产负债率(%) 33.1033.4632.1232.9032.7133.3930.4229.3029.90
 股东权益比率(%) 66.9066.5467.8867.1067.2966.6169.5870.2069.60
 已获利息倍数(倍) -66.88-18.03-33.91-33.57-88.64117.43-153.18-441.69299.87
 流动比率 1.861.831.901.831.801.751.951.981.89
 速动比率 1.401.401.381.271.211.211.181.141.04
发展能力:
 营业收入增长率(%) 20.035.543.652.1128.7724.3639.0436.7024.40
 营业利润增长率(%) 196.02158.4148.8023.16269.17-148.38-75.09-75.5928.82
 税后利润增长率(%) 209.02137.3160.9026.28387.32-158.09-79.97-79.3928.00
 净资产增长率(%) 7.745.940.64-0.59-0.88-2.104.483.3410.05
 总资产增长率(%) 8.366.023.174.002.521.944.700.772.09

前瞻产业研究院